Home mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
Article Open Access

mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study

  • Li Feng , Jiaxin Chen , Qiuyan Luo , Miao Su , Peisong Chen , Rong Lai , Cunzhou Shen , Hongyan Zhou , Haiyan Wang , Xunsha Sun , Ling Chen , Han Xia and Huiyu Feng EMAIL logo
Published/Copyright: March 3, 2023

Abstract

Whether metagenomic next-generation sequencing (mNGS) could benefit patients with suspected severe central nervous system (CNS) infection in terms of diagnosis and antibiotic treatment remains unknown. We retrospectively analyzed 79 patients with suspected CNS infection and undertook mNGS. The value of mNGS was investigated in terms of identification of pathogen and guidance for the adjustment of antibiotic treatment. The relationship between the time of initiating mNGS since onset and the Glasgow Outcome Scale (GOS) score after 90-day follow-up were analyzed. Fifty out of 79 cases with suspicious severe CNS infection were finally diagnosed. Despite previous routine laboratory tests, mNGS further promoted the accurate identification of pathogens in 23 cases (47.9%). The sensitivity, specificity, and accuracy of mNGS test in this study were 84.0, 79.3, and 82.3%, respectively. Furthermore, mNGS facilitated the adjustment of empirical antibiotic treatments in 38 cases (48.1%). The time of taking mNGS since onset had an insignificant weak positive correlation with GOS after 90-day follow-up (r = −0.73, P = 0.08). mNGS facilitated the accurate identification of pathogens in suspicious severe CNS infections and promoted the accurate antibiotic therapy even empirical antibiotics were administrated. It should be taken as early as possible to improve the clinical outcome of patients with suspicious severe CNS infection.

1 Introduction

The central nervous system (CNS) infection is common throughout the world [1]. So far, there are more than 100 microbes which can cause encephalitis or meningitis, and the list keeps growing [2]. The clinical manifestations of CNS infection, including headache, fever, seizures, and alternation of consciousness, are nonspecific, overlapping with that of other CNS diseases, such as autoimmune encephalitis [3]. On the other hand, the sensitivity and specificity of conventional laboratory tests, which usually include cerebrospinal fluid (CSF) analysis, polymerase chain reaction (PCR), CSF culture, and brain biopsy, are unsatisfying. Various factors, such as the increasing pathogenic microbes compared with limited definitive tests, the rare pathogens that spread widely due to globalization, or just the inaccessibility to enough volume of CSF or brain tissue, bring difficulty in identifying pathogens and providing pathogen-specific antibiotic [4,5]. The pathogen of acute meningeal encephalitis is not identified in about 50% cases [5,6].

Timely and accurate diagnosis and treatment are essential to improve the outcome of patients with severe CNS infections. Metagenomic next-generation sequencing (mNGS) is a novel but promising method assisting clinicians to identify pathogens in a rapid target-independent manner. It allows simultaneous and unbiased identification of all microbes with a small volume of single sample [7]. So far, mNGS has been gaining increasing attention of researchers and success in disclosing the rare or unexpected pathogens in piles of infection [5,8,9]. A lot of studies have verified its utility in CNS infection. The overall positive detection rate is approximately 15.7–57% in CNS infection, with a sensitivity of 73–92% and a specificity of 96–99%, depending on the pathogens [1,5,6,8,10]. Although the reliability of mNGS in identifying pathogens of CNS infection is gradually recognized, and the fact that mNGS facilitates the diagnosis and treatment of rare pathogens in CNS infections has been acknowledged, whether the application of mNGS promotes treatment of CNS infection in real world is rarely discussed [5,6]. Empirical antibiotic treatment covering most common pathogens is usually administrated before mNGS in real clinical scenario; this may limit the application of mNGS if the mNGS detection contributes little to treatment adjustment. Therefore, it is necessary to investigate the strength of mNGS in promoting not only diagnosis but also treatment in real clinical scenario.

In this study, we retrospectively analyzed 79 cases admitted to our neurological intensive care unit (NICU) with suspected severe CNS infection during the past 5 years. Before mNGS test, all patients received empirical antibiotic treatment toward pathogens judged by clinical symptoms and routine laboratory testing. In this study, the mNGS significantly facilitated the identification of pathogens as well as promoted the accurate antibiotic treatment profoundly.

2 Methods

2.1 Subjects

Patients admitted to NICU in the First Affiliated Hospital of Sun Yat-Sen University from January 2017 to December 2021 due to suspicious severe CNS infection were enrolled in this study. The inclusion criteria were set as (1) at least one of the following symptoms: fever (>38℃), headache, nausea/vomiting, seizure, meningeal irritation, local neurological dysfunction, and conscious disorder and (2) at least one of the following changes: the infectious CSF and/or the infectious changes on images. The exclusion criteria included: (1) age <18 or >80 years; (2) refused lumbar puncture and/or mNGS of CSF during hospitalization; and (3) pre-existing evidence suggesting other etiology (i.e., positive antibody for autoimmune encephalitis).

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration and has been approved by the ethical review committee of the First Affiliated Hospital of Sun Yat-Sen University.

2.2 Chart review and data collection

The initial diagnoses at registration and the final clinical diagnoses for the enrolled patients were verified by retrospective, in-depth chart review independently performed by two neurologists (Dr FL and Dr FH or Dr CL) and one infectious-disease physician and microbiologist (Dr CP). Any discrepancies in the determination of etiology were resolved by direct communication with treating physicians or by mutual consensus. For cases whose diagnoses meeting the inclusion criteria mentioned above, the general information of patients, including the age, gender, time of onset and registration, main symptoms, physical signs, imaging findings as well as the scores of Glasgow coma scale (GCS) and Acute Physiology and Chronic Health Evaluation II (APACHE Ⅱ) at registration in NICU, was collected. The medical process since onset, the time and details of CSF analysis, the results of PCR and specific antibody against pathogen, and the time and results of mNGS were also recorded. Empirical antibiotics based on initial diagnosis (virus, bacteria, tuberculosis, fungi, parasite, and unidentified pathogens according to the clinical symptoms and routine tests) before mNGS were recorded. For the adjustment of antibiotic regimen after mNGS, the “Add” referred to adding a new sort of antibiotic against another pathogen or a new relevant drug according to revised diagnosis, the “De-escalation” meant degradation or suspension of an antibiotic, while the “Modification” was defined as modifying the antibiotic but still against the same spectrum of pathogen. The overall time and cost of hospitalization, intensive care unit (ICU) duration, and the score of Glasgow Outcome Scale (GOS) after 90-day follow-up were also included.

2.3 Follow-up

The follow-up was carried out on the 90th day after discharge via outpatient clinic, online medical consultation service, or telephone. GOS of the patients with follow-up was recorded to evaluate their disability.

2.4 mNGS of CSF

About 2 mL of CSF was collected and then transmitted on dry ice for PACEseq mNGS detection (Hugobiotech, Beijing, China). The cells in CSF were removed by centrifugation and the supernatant was collected for the subsequent extraction. Cell-free DNA from CSF was extracted using QIAamp DNA Micro Kit (QIAGEN, Hiden, Germany) according to the manufacturer’s instructions. DNA libraries were constructed using QIAseq™ Ultralow Input Library Kit for Illumina (QIAGEN, Hiden, Germany) according to its manual. The quality of constructed libraries was assessed using Qubit (Thermo Fisher, Waltham, USA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, USA). The qualified DNA libraries were sequenced on a Nextseq 550 platform (Illumina, San Diego, USA). Negative controls (sterile deionized water) and positive controls (synthesize fragments with known quantities) were set for each batch of experiments using the same wet lab procedures and bioinformatics analysis as the clinical samples. For the bioinformatics analyses, adapters, short, low-quality, and low-complexity reads were removed from the raw data of each library. The human DNA reads were also filtered out by mapping to human reference database (hg38). The remaining reads were aligned to the Microbial Genome Databases (ftp://ftp.ncbi.nlm.nih.gov/genomes/) using Burrows-Wheeler Aligner software. The reads number and reads per million (RPM) of each detected pathogen was calculated. For detected microbes, including bacteria (Mycobacteria excluded), fungi (Cryptococcus excluded), and parasites, a positive mNGS result was given when its coverage ranked top10 of the same kind of microbes and absent in the negative control (“No template” control, NTC) or when its ratio of RPM between sample and NTC (RPMsample/RPMNTC) > 10 if RPMNTC ≠ 0. For viruses, Mycobacteria, and Cryptococcus, a positive mNGS result was considered when at least 1 unique read was mapped to species level and absent in NTC or RPMsample/RPMNTC >5 when RPMNTC ≠ 0.

2.5 Statistical analysis

SPSS 17.0 was used to analyze the relevant data. Descriptive statistics were used for demographic information as Mean ± SD. The data that were not normally distributed were described as [M(Q L , Q U )]. The proportion of specified group was presented as percentage. The relationship between the timing of mNGS and clinical outcome was tested by Spearman’s correlation analysis.

3 Results

3.1 General data

A total of 79 cases (male:female = 57:22) with initial diagnosis of suspicious severe CNS infection at admission were enrolled into this study during 2017–2021. The age of these patients was 43.29 ± 19.76 years old; their GCS and APACHE Ⅱ score at the registration of NICU were 6.41 ± 3.54 and 16.87 ± 4.93, respectively. The average time of starting empiric antibiotics administration was 10.80 ± 13.44 days since onset. The average time of taking the first mNGS since onset was 18.61 ± 15.64 days. The general information and clinical characteristics of the 79 patients are listed in Table 1.

Table 1

Demographic and clinical characteristics of the 79 patients

Characteristic Value
Age – M ± SD 43.29 ± 19.76
Male:female – n 57:22
Syndrome – n (%)
 Meningitis 7 (8.9)
 Encephalitis with or without meningitis 64 (81.0)
 Myelitis with or without meningitis 8 (10.1)
Exacerbation of chronic condition – n (%) 9 (11.4)
Immunocompromised – n (%) 12 (15.2)
 Solid-organ transplant 2 (2.5)
 Chemotherapy 6 (7.6)
 Immunosuppression for non-neoplastic condition 4 (5.7)
GCS at ICU registration – M ± SD 6.41 ± 3.54
APACHE Ⅱ at ICU registration – M ± SD 16.87 ± 4.93
Mean length of stay (day) – M(Q L , Q U )
 In hospital 32 (21,56)
 In ICU 18 (8,28)
Median no. of days after onset that antibiotics were used against CNS infection (day) – M(Q L , Q U ) 7.5 (2.75, 14)
Median no. of days after onset that CSF was collected for metagenomic NGS (day) – M(Q L , Q U ) 15 (8,27)
Mean total cost (U.S.$) – M(Q L , Q U ) 29,618 (13,341, 50,720)

Symptoms had been present for more than 4 weeks.

Among the 79 patients, mNGS of CSF provided 48 positive results and 31 negative results. The empirical judgment on pathogen has been revised in 46 (58.2%) cases by mNGS, among which there were 23 positive mNGS results and 23 negative results. 50 patients were finally diagnosed with severe CNS infections. According to the final diagnosis, the number of cases with true positive, false positive, true negative, and false negative results by mNGS was 42, 6, 23, and 8, respectively. The sensitivity of mNGS in identifying pathogens of severe CNS infection shown in this study was 84.0%, while the specificity was 79.3%. The accuracy of mNGS in this study was 82.3%.

There were 38 patients (48.1%) went through adjustment of antibiotics based on the mNGS results. Antibiotics were added in 18 cases (22.8%), de-escalated in 20 cases (25.3%), and modified in 7 cases (8.7%) (Figure 1). Five patients received addition and de-escalation of antibiotic treatment simultaneously, and two patients went through modification simultaneously with addition or de-escalation.

Figure 1 
                  The adjustment of antibiotic treatment of severe CNS infection owing to mNGS results. The separated squares with different color of each column represented the adjustment of antibiotics according to mNGS results.
Figure 1

The adjustment of antibiotic treatment of severe CNS infection owing to mNGS results. The separated squares with different color of each column represented the adjustment of antibiotics according to mNGS results.

3.2 Cases with positive mNGS detection

There were 48 cases (M:F = 33:15) detected with positive mNGS results in this study, and 42 were verified as CNS infection. Compared with the empirical judgment on pathogen, mNGS has helped to determine pathogens in 15 cases with unidentified clinical and laboratory characteristics and thoroughly changed the categories of pathogens in 6 cases in further, mainly from virus or bacteria to other pathogens. It also helped to expand the pathogen spectrum in additional 2 cases. Totally, mNGS promoted the pathogen identification in 47.9% cases (23) when the result was positive. More details are in Figure 2 and Table 2.

Figure 2 
                  The spectrum of pathogens among patients with positive mNGS results. (a) The pathogen spectrum judged by empirical judgment and mNGS, respectively. The number represented the percentage of pathogens among the positive mNGS cases by empirical judgment and mNGS, respectively. (b) The judgment on the spectrum of pathogens has been profoundly changed by mNGS. The rows named unidentified/virus/bacteria/fungi represented the case number of each pathogen spectrum judged by clinical data and routine CSF tests before mNGS, the rows named mNGS-U/V/B/F represented the case number of each pathogen identified by mNGS.
Figure 2

The spectrum of pathogens among patients with positive mNGS results. (a) The pathogen spectrum judged by empirical judgment and mNGS, respectively. The number represented the percentage of pathogens among the positive mNGS cases by empirical judgment and mNGS, respectively. (b) The judgment on the spectrum of pathogens has been profoundly changed by mNGS. The rows named unidentified/virus/bacteria/fungi represented the case number of each pathogen spectrum judged by clinical data and routine CSF tests before mNGS, the rows named mNGS-U/V/B/F represented the case number of each pathogen identified by mNGS.

Table 2

The diagnosis and treatment adjustment of patients with positive mNGS

Pathogens empirically supposed Pathogens identified by mNGS Treatment adjustment
Species No. Species No. Adjustment Percentage
Virus-Ua 12 Virusb 7 Add 25
Strongyloides stercoralis 1 De-escalation 66.7
TB 3 Unchanged 25
Norcardia 1
Mucor 1
Bacteriac 12 Bacteriad 8 Add 54.6
CMV 1 De-escalation 18.2
TB 2 Modification 18.2
Fungi 3 Unchanged 27.3
Fungi 3 Cryptococcus 2 Modification 33.3
Coccidioides 1
Unidentifiede 15 Virusf 6 Add 46.7
Bacteriag 6 De-escalation 13.3
TB 3 Modification 26.7
Aspergillus funigatus 1 Unchanged 26.7
Angiostrongylus cantonesis 1
Nargleria fowleri 1

a Strongyloides stercoralis co-existed with HV-5 (1), CMV & HV-α (1); bCMV, HV-α, HV-δ, HV-ε, β-HPV-1, HPV-5, HZV; c Streptococcus pneumoniae coexisted with Aspergillus; CMV coexisted with Listeria monocytogenes; d Listeria monocytogenes, Norcardia, Streptococcus intermedius, Streptococcus pneumoniae, Staphylococcus, Roseomonas mucosa; e Acinetobacter baumannii co-existed with Stenotrophomonas maltophilia; fHV-α, EBV, CMV, Parvovirus; g Klebsiella pneumoniae, Norcardia, Acinetobacter baumannii, Stenotrophomonas maltophilia, Streptococcus suis, Abbreviations: U: unclassified; CMV: Cytomegalovirus; HV: Herpus virus; HPV: Human paliiomavirus; HZV: Herpes zoster virus; TB: tuberculosis; EBV: Epstein-Barr virus.

mNGS promoted the optimization of antibiotic treatment in 29 out of 48 with positive mNGS results (60.4%), including 12 (25.0%) with de-escalation of antibiotics, 7 (14.6%) with modification toward more targeted antibiotics, and 17 (35.4%) with added antibiotics. In addition, mNGS results facilitated the decision of surgery in 2 cases (4.2%). Thirteen cases (39.6%) remained their antibiotic treatment, because the initial empirical treatment had covered the pathogens identified by mNGS (Figure 1), or simultaneous infection of other organ (mostly pneumonia) was considered. Five of the six false-positive cases remained their previous antibiotic treatments due to infection of other organs. Only one went through de-escalation because of the absence of virus in mNGS result.

There were 28 CSF samples sent for culture or direct microscopy, and only to get 5 (17.8%) positive results. Among the five positive samples, three suggested cryptococcus, and one suggested fungus without specific specie. Another one was considered contamination. The three cryptococcus-positive CSF samples were the only samples with which the conventional test identified pathogens prior to mNGS and promoted the adjustment of antibiotic regimen.

Six (12.5%) cases were finally identified as mNGS false positive, with the final diagnosis of acute disseminated encephalomyelitis (ADEM) (2), anti-NMDA-receptor encephalitis (anti-NMDARE) (1), septic encephalopathy (1), autoimmune encephalitis with negative antibody (1), and cerebral bleeding (1). The false positive rate of mNGS was 7.6%. The clinical characteristics and mNGS discoveries of six cases are listed in Table 3.

Table 3

The information of patient with false-positive mNGS

mNGS Clinical diagnosis Treatment
Pathogen identified No. Final diagnosis No.
HV-4 1 ADEM 2 Unchanged
Klebsiella pneumoniae 1
Pseudomonas stutzeri 1 Autoimmune encephalopathy with negative antibody 1 Unchanged
Micrococcus luteus 1 NMDARE 1 Unchanged
CMV 1 Septic/metabolic encephalopathy 2 Unchanged
HPV 1

3.3 Cases with negative mNGS detection

Thirty-one patients (M:F = 24:7) were tested with negative mNGS results. The mNGS helped to revise the etiology of 74.2% (23) cases with negative findings. The 23 cases with true negative results were eventually diagnosed as AE (1), probable AE (4), possible AE with negative antibody (11), ADEM (2), cerebrovascular disease (1), fatal familiar insomnia (1), meningeal carcinoma (1), hypoxic ischemic encephalopathy (1), and metabolic encephalitis (1). Eight (25.8% of the cases with negative mNGS) cases were considered mNGS false negative, among which 2 cases were finally diagnosed with tuberculosis via the second mNGS and Xpert test, one was diagnosed with Japanese B encephalitis infection by specific antibody test and MRI, and five cases were diagnosed with abortive bacterial infection based on the disclosure of lesion in the inner ear, characteristics of CSF, and the efficacy of antibiotic therapy (Table 4).

Table 4

The diagnosis of patients with false negative mNGS

Patient no. Age (years) Gender Syndrome Pathogen Approaches to diagnosis
A 39 M Meningitis Bacteria Discover the inner ear abscess
B 48 M Meningoencephalitis Bacteria The clinical and CSF characteristics, effective antibiotic treatment
C 56 M Encephalitis Bacteria and/or virus
D 59 M Encephalitis Bacteria
E 56 M Encephalitis Tuberculosis The second CSF mNGS and specialist consultation
F 14 M Encephalitis with myelitis Bacteria Discover the inner ear abscess
G 34 M Meningoencephalitis Japanese B virus Specific antibody test
H 47 M Encephalitis Tuberculosis CSF-Xpert, specialist consultation, effective anti-TB treatment
I 19 M Meningitis FFI Genetic screen and PCR (D178N mutation)

FFI: fatal familiar insomnia.

Eight cases (25.8%) went through degradation or even terminating the initial empirical antibiotic treatment according to the negative mNGS results. One (3.33%) case was added with high-dose steroid intravenous impulse due to the absence of infection verified by the negative mNGS (Figure 1). There were 22 (71.0%) cases continuing their antibiotic regimen, mainly because simultaneous infection of other organs (such as pneumonia) or the worry about CNS infection with unknown virus. Besides, 5 out of the 22 cases received other antibiotics, which did not target CNS infection after a sufficient dosage and duration of initial empirical antibiotics.

3.4 Follow-up

Totally, 70 patients were followed up and 9 were lost (Figure 3). The total mortality was 37.1% and the total recovery ratio was 21%. The average GOS score of patients with severe CNS infection was 2.93 ± 1.71 on the 90th day after discharge.

Figure 3 
                  The GOS score of patients with suspected severe CNS infection at the 90th day after discharge.
Figure 3

The GOS score of patients with suspected severe CNS infection at the 90th day after discharge.

Spearman’s correlation analysis of the relationship between the time of mNGS and GOS suggested the r = −0.30, (P = 0.68). The time of taking mNGS since onset had an insignificant negative correlation with GOS after 90-day follow-up (Figure 4).

Figure 4 
                  The correlation between the patients’ outcome and the timing of mNGS. DAO: day after onset.
Figure 4

The correlation between the patients’ outcome and the timing of mNGS. DAO: day after onset.

4 Discussion

There is intensive interest of mNGS in identifying pathogens of infectious diseases, including CNS infection. Most of previous studies focused on the accuracy of mNGS in identifying pathogens in comparison with conventional microbiological testing [1,5,6,10]. Clinicians usually recognize suspicious CNS infection by symptoms and prescribe antibiotics empirically at the beginning; then, they adjust antibiotics according to routine CSF testing subsequently. Since the empirical antibiotic treatment of CNS infection often cover the majority of common bacteria and viruses, sometimes even Mycobacterium tuberculosis, whether taking mNGS could still benefit the patients with severe CNS infection is the question of our interest. In this study, we investigated the effectiveness of mNGS in terms of diagnosis and antibiotic treatment. We found that mNGS did promote the pathogen identification as well as the accurate antibiotic treatment of critical CNS infection even empirical diagnosis and antibiotics had been established according to clinical manifestations and conventional laboratory testing.

CNS infection has overlapping clinical and laboratory characteristics with other neurological diseases [5]. Furthermore, even the diagnosis of CNS infection is determined. It is difficult to identify the spectrum of pathogen due to the atypical CSF characteristics in many severe cases. The empirical judgment on pathogens may easily lead to mistakes (Figure 2). mNGS in this study has helped to identify the pathogens for 15 cases in which the specific spectrum of pathogens was difficult to be determined by conventional CSF testing and thoroughly changed the empirical judgment on pathogen spectrum for another 12 cases. In addition, it has expanded the pathogen spectrum for 2 cases. These rare pathogens identified by mNGS in severe CNS infections include parasites, Cryptococcus, Coccidioides, Rhizopus, Aspergillus, Mycobacteria, and so on [11,12]. These pathogens were hard to be detected by routine laboratory tests and some may even out of the consideration of physicians. mNGS takes the advantage of target-independent screening to identify all known pathogens in a sample and elicits great effect on the quick identification of unexpected microbes responsible for severe CNS infection. The effectiveness of mNGS in disclosing the rare intracranial pathogens has been verified by a serial of cases previously reported [13]. The appropriate threshold value of the species-specific read number or genus-specific read numbers for different pathogens has been proposed in order to minimize the false positive findings [1]. It has also acknowledged that mNGS has a relatively high positive prognostic value between 15.7 and 57%, as well as the sensitivity of 73% and the specialty of 99% [1,5,6,13]. Our study provided similar result and supported the value of mNGS in detecting pathogens of severe CNS infection. The overall accuracy of detection of the study was 81.0%, and the sensitivity was even as high as 82.4% while the specificity was 78.6%.

Furthermore, the investigation on the value of mNGS in real practice should go beyond the identification of pathogens. The empirical antibiotic treatment is usually initiated at the moment of CNS infection was suspected and might be adjusted according to the routine CSF analysis followed. Therefore, the practical value of mNGS also concerns whether its merit in accurate identification of pathogens could help to optimize the antibiotic treatment in real practice, because the routine CSF tests, such as the measurement of CSF pressure, the cytology, and biochemistry of CSF, have provided etiological cues a little earlier than mNGS. Given the atypical symptoms of CNS infection and low sensitivity and specificity of conventional CSF testing, great bias in pathogen judgment may exist, resulting in failure in covering pathogens. Even the pathogens were covered, the combined broad-spectrum antibiotics, which used to be empirically applied against suspicious CNS infection, may lead to the abuse of antibiotics [14,15,16,17]. In this study, all patients had received empirical antibiotics prior to mNGS results, some even had undergone adjustment according to conventional CSF tests before mNGS results. However, there were still nearly 50% patients benefited from mNGS in terms of optimizing antibiotic therapy. Furthermore, among the patients with positive mNGS results, promotion of antibiotic treatment by mNGS has been observed in 60.4% cases (Figure 1), mainly toward precision of antibiotics and getting rid of unnecessary drugs. Moreover, the previous study has suggested that the negative mNGS results can help rule out infections, especially in immunocompromised patients [5]. In this study, 29.0% of mNGS-negative cases can be benefited from the de-escalation of empirical antibiotic regimen. Thus, mNGS facilitated the accurate antibiotic treatment by identifying pathogens in severe CNS infection.

In this study, six cases were found with false-positive mNGS detection. The positives were attributed to sample contamination from the environment or normal human flora. Fortunately, the diagnosis and treatment of all these cases were not misled by mNGS owing to the reference of clinical data and conventional laboratory testing (Tables 1 and 3). Eight cases were found false negative; compartmentalized infection (abscess from inner ear) was an important reason for these negative mNGS findings. Antibiotic treatment before mNGS may also contribute to the negative results. In addition, the timing of mNGS and the low abundance or even absence of some specific pathogens in CSF (such as Borrelia burgdorferi) may lead to false-negative mNGS results [5,8]. In the study, 74.2% cases with negative mNGS remained their antibiotic treatment with consideration of the complicated infection of other organs or occult infection, especially when the results of mNGS and autoimmune antibodies were both negative [3,5,18,19]. It is suggested that mNGS should be interpreted with clinical context and clinical reasoning.

The decision about the appropriate timing for mNGS was still considered to be made on a case-by-case basis [8]. A health-care economics modeling study based on actual insurance payments for hospitalized patients with CNS infection found that an opportunity exists for mNGS testing to be cost-effective in patients who are critically ill [20].

The follow-up was carried out at the 90th day after discharge of NICU and suggested that the overall mortality of severe CNS infection was as high as 37.1% while the severe disability reached 18.6%. The GOS score of the 90-day follow-up has indicated a negative correlation with the timing of mNGS since onset, but with no statistical significance. Theoretically, the early mNGS is taken, the earlier pathogens are identified, and specific antibiotics could be administrated, avoiding abuse of antibiotics and its complications [21,22]. There are three reasons for the insignificant correlation between the timing of mNGS and the patients’ outcome. On one hand, the rapid progression of severe CNS infection may result in relatively high mortality and disability even receiving early mNGS diagnosis and specific treatment. On the other hand, the mNGS may be delayed due to the consideration on expense in less severe cases which presented better outcome. Therefore, the later mNGS was carried out, the lower GOS score at the 90th day was (Figure 4). Besides, the sample size of this study may be too small to reveal the significance. Previous studies showed that the clinical outcome of severe CNS patients is more affected by systemic status than by the dysfunction of CNS. The early definitive diagnosis and precision medicine may lead to systemic benefit [15,16,22]. Therefore, we still recommend taking mNGS as early as possible in the context of severe CNS infection.

This study suggested that mNGS is of important strength in promoting the accuracy of diagnosis and antibiotic treatment of severe CNS infection, even with the pre-establishment of empirical judgment on pathogens and empirical antibiotic treatment before mNGS. In the severe CNS infection cases, mNGS, as a powerful assistance to clinicians, facilitated the identification of pathogens and improved the accurate antibiotic treatment. It should be taken as early as possible when patients are suspected as severe CNS infection.


# These authors contributed equally to this manuscript.

tel: +86-13247594957

Acknowledgments

The authors thank all patients and their families, as well as all medical staffs involved.

  1. Funding information: This study was supported by grants from the clinical research supporting program for Lingnan Junior doctors of Guangdong province medical association(2021067), Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases (2020B1212060017), Guangdong Provincial Clinical Research Center for Neurological Diseases (2020B1111170002), Southern China International Joint Research Center for Early Intervention and Functional Rehabilitation of Neurological Diseases (2015B050501003 and 2020A0505020004), and Guangdong Provincial Engineering Center for Major Neurological Disease Treatment, Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease, Guangzhou Clinical Research and Translational Center for Major Neurological Diseases (201604020010).

  2. Author contributions: F.L., C.L., and F.H. reviewed the charts and analyzed the data. C.J. took the follow-up and analyzed data. F.L., L.Q., S.M., and L.R. collected data and reviewed the literature. C.P. took consultation as an infectious disease physician and microbiologist. S.C., Z.H., W.H., and S.X. participated in clinical management. X.H. contributed in the mNGS procedure and mNGS result analysis, as well as the associated description in Method section. F.L. wrote the manuscript, and F.H. reviewed the manuscript. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work. The authors applied the SDC approach for the sequence of authors.

  3. Conflict of interest: Han Xia is employed by Hugobiotech Co., Ltd. He exclusively took charge of the analysis of mNGS and was kept blind to the other parts of this study. The other authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Xing XW, Zhang JT, Ma YB, He MW, Yao GE, Wang W, et al. Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: A large, prospective case series of 213 patients. Front Cell Infect Microbiol. 2020;10:88. 10.3389/fcimb.2020.00088. PubMed PMID: 32211343; PubMed Central PMCID: PMCPMC7066979 Epub 2020/03/27.Search in Google Scholar PubMed PubMed Central

[2] Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835–44. Epub 2010/10/19. 10.1016/S1473-3099(10)70222-X. PubMed PMID: 20952256.Search in Google Scholar PubMed

[3] Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404. Epub 2016/02/26 10.1016/S1474-4422(15)00401-9. PubMed PMID: 26906964; PubMed Central PMCID: PMCPMC5066574.Search in Google Scholar PubMed PubMed Central

[4] Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370(25):2408–17. Epub 2014/06/05. 10.1056/NEJMoa1401268. PubMed PMID: 24896819; PubMed Central PMCID: PMCPMC4134948.Search in Google Scholar PubMed PubMed Central

[5] Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med. 2019;380(24):2327–40. Epub 2019/06/13. 10.1056/NEJMoa1803396. PubMed PMID: 31189036; PubMed Central PMCID: PMCPMC6764751.Search in Google Scholar PubMed PubMed Central

[6] Zhang Y, Cui P, Zhang HC, Wu HL, Ye MZ, Zhu YM, et al. Clinical application and evaluation of metagenomic next-generation sequencing in suspected adult central nervous system infection. J Transl Med. 2020;18(1):199. Epub 2020/05/15. 10.1186/s12967-020-02360-6. PubMed PMID: 32404108; PubMed Central PMCID: PMCPMC7222471.Search in Google Scholar PubMed PubMed Central

[7] Forbes JD, Knox NC, Ronholm J, Pagotto F, Reimer A. Metagenomics: The next culture-independent game changer. Front Microbiol. 2017;8:1069. 10.3389/fmicb.2017.01069 PubMed PMID: 28725217; PubMed Central PMCID: PMCPMC5495826. Epub 2017/07/21.Search in Google Scholar PubMed PubMed Central

[8] Ramachandran PS, Wilson MR. Metagenomics for neurological infections - expanding our imagination. Nat Rev Neurol. 2020;16(10):547–56. Epub 2020/07/15 10.1038/s41582-020-0374-y. PubMed PMID: 32661342; PubMed Central PMCID: PMCPMC7356134.Search in Google Scholar PubMed PubMed Central

[9] Duan H, Li X, Mei A, Li P, Liu Y, Li X, et al. The diagnostic value of metagenomic next rectanglegeneration sequencing in infectious diseases. BMC Infect Dis. 2021;21(1):62. Epub 2021/01/14. 10.1186/s12879-020-05746-5. PubMed PMID: 33435894; PubMed Central PMCID: PMCPMC7805029.Search in Google Scholar PubMed PubMed Central

[10] Miller S, Naccache SN, Samayoa E, Messacar K, Arevalo S, Federman S, et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res. 2019;29(5):831–42. Epub 2019/04/18. 10.1101/gr.238170.118. PubMed PMID: 30992304; PubMed Central PMCID: PMCPMC6499319.Search in Google Scholar PubMed PubMed Central

[11] Feng L, Zhang A, Que J, Zhou H, Wang H, Guan Y, et al. The metagenomic next-generation sequencing in diagnosing central nervous system angiostrongyliasis: a case report. BMC Infect Dis. 2020;20(1):691. Epub 2020/09/23. 10.1186/s12879-020-05410-y. PubMed PMID: 32957922; PubMed Central PMCID: PMCPMC7507257.Search in Google Scholar PubMed PubMed Central

[12] Zou Q, Chen P, Chen J, Chen D, Xia H, Chen L, et al. Multisystem involvement induced by human parvovirus B19 infection in a non-immunosuppressed adult: A case report. Front Med (Lausanne). 2022;9:808205. Epub 2022/05/03. 10.3389/fmed.2022.808205. PubMed PMID: 35492345; PubMed Central PMCID: PMCPMC9039281.Search in Google Scholar PubMed PubMed Central

[13] Consensus Group Of Experts On Application Of Metagenomic Next Generation Sequencing In The Pathogen Diagnosis In Clinical Moderate And Severe Infections, Professional Committee Of Sepsis And Shock Chinese Research Hospital Association, Professional Committee Of Microbial Toxins Chinese Society For Microbiology, Professional Committee Of Critical Care Medicine Shenzhen Medical Association. Expert consensus for the application of metagenomic next generation sequencing in the pathogen diagnosis in clinical moderate and severe infections. (1st edn). Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(5):531–6. Epub 2020/06/25. 10.3760/cma.j.cn121430-20200228-00095. PubMed PMID: 32576342.Search in Google Scholar PubMed

[14] Al-Sunaidar KA, Prof Abd Aziz N, Prof Hassan Y. Appropriateness of empirical antibiotics: risk factors of adult patients with sepsis in the ICU. Int J Clin Pharm. 2020;42(2):527–38. Epub 2020/03/08. 10.1007/s11096-020-01005-4. PubMed PMID: 32144611.Search in Google Scholar PubMed

[15] Campion M, Scully G. Antibiotic use in the intensive care unit: Optimization and de-escalation. J Intensive Care Med. 2018;33(12):647–55. Epub 2018/03/15. 10.1177/0885066618762747. PubMed PMID: 29534630.Search in Google Scholar PubMed

[16] Montrucchio G, Sales G, Corcione S, De Rosa FG, Brazzi L. Choosing wisely: what is the actual role of antimicrobial stewardship in Intensive Care Units? Minerva Anestesiol. 2019;85(1):71–82. Epub 2018/07/12. 10.23736/S0375-9393.18.12662-9. PubMed PMID: 29991221.Search in Google Scholar PubMed

[17] Ciummo F, Srinivas P, Biedny J. Antimicrobial use in central nervous system infections. Curr Opin Infect Dis. 2021;34(3):255–63. Epub 2021/03/21. 10.1097/QCO.0000000000000721. PubMed PMID: 33741793.Search in Google Scholar PubMed

[18] Gastaldi M, Mariotto S, Giannoccaro MP, Iorio R, Zoccarato M, Nosadini M, et al. Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study. Eur J Neurol. 2020;27(4):633–43. Epub 2019/12/10. 10.1111/ene.14139. PubMed PMID: 31814224.Search in Google Scholar PubMed

[19] Carbo EC, Blankenspoor I, Goeman JJ, Kroes ACM, Claas ECJ, De Vries JJC. Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield. Expert Rev Mol Diagn. 2021;21(11):1139–46. Epub 2021/10/06. 10.1080/14737159.2021.1985467. PubMed PMID: 34607520.Search in Google Scholar PubMed

[20] Fulton BD, Proudman DG, Sample HA, Gelfand JM, Chiu CY, DeRisi JL, et al. Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis. PLoS One. 2020;15(1):e0226895. Epub 2020/01/16. 10.1371/journal.pone.0226895. PubMed PMID: 31940319; PubMed Central PMCID: PMCPMC6961903.Search in Google Scholar PubMed PubMed Central

[21] Kollef MH, Shorr AF, Bassetti M, Timsit JF, Micek ST, Michelson AP, et al. Timing of antibiotic therapy in the ICU. Crit Care. 2021;25(1):360. Epub 2021/10/17. 10.1186/s13054-021-03787-z. PubMed PMID: 34654462; PubMed Central PMCID: PMCPMC8518273.Search in Google Scholar PubMed PubMed Central

[22] Murphy CV, Reed EE, Herman DD, Magrum B, Beatty JJ, Stevenson KB. Antimicrobial Stewardship in the ICU. Semin Respir Crit Care Med. 2022;43(1):131–40. Epub 2022/02/17. 10.1055/s-0041-1740977. PubMed PMID: 35172363.Search in Google Scholar PubMed

Received: 2022-10-31
Revised: 2023-01-16
Accepted: 2023-01-23
Published Online: 2023-03-03

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 21.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0578/html?licenseType=open-access
Scroll to top button